Compare PLAG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAG | VNRX |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | 6 | 75 |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 7.2M |
| IPO Year | 2007 | 2012 |
| Metric | PLAG | VNRX |
|---|---|---|
| Price | $0.70 | $0.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.62 |
| AVG Volume (30 Days) | 636.8K | ★ 1.7M |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.56 | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,040,616.00 | $1,727,384.00 |
| Revenue This Year | N/A | $57.67 |
| Revenue Next Year | N/A | $240.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $0.49 | $0.13 |
| 52 Week High | $6.81 | $3.26 |
| Indicator | PLAG | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 28.13 |
| Support Level | $0.65 | $0.22 |
| Resistance Level | $0.77 | $0.27 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 39.13 | 24.11 |
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.